Digital architecture for pharmaceutical manufacturing, AI governance, and the structures that let intent and data transfer without losing meaning.
The life sciences industry invests heavily in digital technologies, yet manufacturers continue to struggle with fragmented data, manual reconciliation, and limited return. This paper argues the root cause is architectural, not technological. It introduces the Intent-Driven Digital Core (IDDC) — a four-layer framework (Semantic, Event, Context, Evidence) that preserves manufacturing intent as a persistent, machine-readable construct across the full product lifecycle. Building on ISA-88, ISA-95, and ICH guidance, the IDDC makes technology transfer repeatable rather than bespoke, shifts batch disposition from retrospective reconstruction to continuous evaluation, and gives AI the contextual grounding required for trust in regulated environments.
What's inside: Manufacturing intent as the architectural anchor · the IDDC reference architecture · ontology as a contract of meaning · people as an architectural dependency · digital technology transfer as the ultimate stress test · AI enablement as a consequence of architecture · an alarm-management case study in cell therapy manufacturing.
An Organizational Model for AI in Regulated Manufacturing
Centralized AI governance in regulated manufacturing creates a structural paradox: restrictive policies meant to manage risk drive AI use underground into a shadow tier — invisible, ungoverned, and disconnected from organizational learning. In April 2026, the FDA's first warning letter citing inappropriate AI use in pharmaceutical manufacturing turned that shadow tier from a theoretical risk into a documented enforcement trigger. This paper proposes an integrated architecture — sandbox environments for structured experimentation, a competency-tier model coupling training with tool access, and AI stewards (named individuals with dual fluency in domain expertise and AI literacy, carrying explicit GxP accountability). The components exist independently across industries; the argument is that they are interdependent by design. The integration is the contribution.
Also introduces: the Attributable–Observable–Correctable design discipline for human oversight of AI outputs, and the GxP-steward specification for functions where AI influences quality decisions.
Industry-body work developed with peers across the biopharmaceutical sector. The documents are published by the collaborating organization; these are abstracts with links to the source.
IT Digital & Data Phorum · Co-author
Batch disposition today remains largely manual, fragmented, and inconsistent across sites — a poor fit for the complexity and pace of modern biopharmaceutical supply. This BioPhorum paper sets out a shared industry vision and a practical framework for moving from retrospective, paper-bound release toward automated, data-driven, globally harmonized disposition. It names the core challenges, the strategic opportunities, and the guiding principles teams can use to assess their maturity and chart a path forward.
IT Digital & Data Phorum · Co-author
The barrier to trustworthy AI in biopharma is rarely the model — it's whether the underlying data is ready. This BioPhorum framework defines what makes data AI-ready — suitability, observability, machine-understandability, and availability — and shows how those requirements scale with use case and risk. It confronts data fragmentation, regulatory complexity, and organizational barriers, and offers actionable practices: treating data as a product and building the knowledge layers that make AI adoption scalable and defensible across discovery, manufacturing, quality, and supply chain.
The three-part LinkedIn series the white paper is built on: the shadow tier, training without tooling, and the AI steward.
Operational ReadinessA two-part field-note series on why good systems stall at the floor — and the readiness discipline that fixes it.
Shared semantic structures so process intent survives technology transfer instead of being reconstructed, site by site.
Reframing batch release as a continuous, go/no-go discipline under an intent-driven digital core.